Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Arvid Wallgrens Backe 20, Göteborg,västra Götalands Län 413 46,sweden
- in****@****uet.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.obliquet.com
- HQ
- Göteborg, Västra Götalands Län
Oblique Therapeutics Ab (Publ.) Questions
Oblique Therapeutics Ab (Publ.)'s website is http://www.obliquet.com
Oblique Therapeutics Ab (Publ.)'s LinkedIn profile is https://se.linkedin.com/company/oblique-therapeutics-ab
Oblique Therapeutics Ab (Publ.) has
17 employees.
View email and phone details for 17
employees at Oblique Therapeutics Ab (Publ.).
Oblique Therapeutics Ab (Publ.)'s industry is
Pharmaceutical Manufacturing
Oblique Therapeutics Ab (Publ.)'s top competitors are
Moberg Pharma Ab,
Emplicure,
Irlab Therapeutics Ab,
Vicore Pharma Ab,
Alligator Bioscience Ab,
Stayble Therapeutics,
Aax Biotech Ab,
Cereno Scientific,
Wntresearch Ab,
Fluicell.
Oblique Therapeutics Ab (Publ.)'s support email address is info@obliquet.com
Oblique Therapeutics Ab (Publ.)'s categories are Pharmaceutical Manufacturing
Oblique Therapeutics Ab (Publ.)'s founding year is 2015
